RANDAL "RAN" MOORE, TOP 2024 PHILANTHROPIC HONOREES"
RANDAL "RAN" MOORE, INCLUDED IN THE TOP 2024 PHILANTHROPIC HONOREES"
Randal "Ran" Moore's significant philanthropic involvement particularly through the Moore Family Trust F,oundation and, gifts to institutions like Harvard Medical School among others for 2024. A Transformational 2024 endowment includes support for Harvard Medical School, with at least one $20 million gift identified in annual overviews, among several other endowments, or outright gifts.
Lisa Hubert
Executive Director of Philanthropic Initiatives
www. Lhubert@moorecapitalholdings.com
617-202-7077
"There is an urgent need for personalized medicine in Rheumatology
GNS Healthcare, an artificial intelligence company creating in silico patients that
simulate drug treatment at the individual patient level, and Scipher Medicine, a precision immunology company matching patients with the most effective therapy, today announced plans to develop and launch Gemini - The in silico Patient™ for
rheumatoid arthritis (RA), to help patients reach target treatments sooner.
The in silico Patient is fueled by Scipher Medicine's rich and proprietary clinico-genomic patient data in RA, generated from PrismRA™, the company's commercially available liquid signature blood test that predicts non-response to TNFi therapies in
rheumatoid arthritis patients.